Spironolactone As a Novel DMARD in Rheumatoid Arthritis.

被引：0
|
作者：
Verma, Inderjeet [1 ]
Krishan, Pawan [2 ]
Syngle, Ashit [3 ]
机构：
[1] Punjabi Univ Patiala, Chandigarh, India
[2] Punjabi Univ Patiala, Patiala, Punjab, India
[3] Fortis Multispecial Hosp, Healing Touch City Clin, Chandigarh, India
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1450
引用
收藏
页码：S639 / S640
页数：2
相关论文
共 50 条
  • [1] SPIRONOLACTONE AS A NOVEL DMARD IN RHEUMATOID ARTHRITIS: BENCH TO BED SIDE STUDY
    Verma, I
    Syngle, A.
    Krishan, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 41 - 41
  • [2] Selection of DMARD therapy in early rheumatoid arthritis.
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S269 - S269
  • [3] Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses?
    Ferraccioli, GF
    Casatta, L
    DiPoi, E
    Damato, R
    Bartoli, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) : 336 - 337
  • [4] Discontinuation of DMARD after remission in patients with rheumatoid arthritis.
    Park, YB
    Kim, JM
    Lee, SK
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S277 - S277
  • [5] Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses? Reply
    ODell, JR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) : 337 - 337
  • [6] Novel DMARD monotherapy in rheumatoid arthritis
    Molto, Anna
    Dougados, Maxime
    [J]. LANCET, 2019, 393 (10188): : 2277 - 2278
  • [7] DMARD use and response in relation to lymphoma risk in rheumatoid arthritis.
    Baecklund, E
    Ekbom, A
    Iliadou, A
    Askling, J
    Feltelius, N
    Backlin, C
    Sundström, C
    Klareskog, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S482 - S482
  • [8] Rates and predictors of DMARD use in a cohort of elderly patients with rheumatoid arthritis.
    Schmajuk, Gabriela
    Schneeweiss, Sebastian
    Katz, Jeffrey N.
    Weinblatt, Michael E.
    Setoguchi, Soko
    Avom, Jerry
    Levin, Raisa
    Solomon, Daniel H.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S342 - S343
  • [9] Utility of outcome measures in decisions to change DMARD therapy for rheumatoid arthritis.
    Canvin, JMG
    Chalmers, IM
    El-Gabalawy, HS
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S126 - S126
  • [10] Safety of DMARD combination therapy to single drug treatment in early rheumatoid arthritis.
    LeirisaloRepo, M
    Kautiainen, H
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 122 - 122
12345